ConductScience.org, home

Paper42940171PubMed

Lipid Nanoparticle Delivery of CAR276 mRNA Enables Antigen-Specific Cytotoxicity in T Cells Against Glioblastoma Cells.

Zahedipour F and 9 others. Biomedicines, 2026.

Cite this record

ConductScience Library. Lipid Nanoparticle Delivery of CAR276 mRNA Enables Antigen-Specific Cytotoxicity in T Cells Against Glioblastoma Cells. Papers, record 42940171. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42940171

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Lipid Nanoparticle Delivery of CAR276 mRNA Enables Antigen-Specific Cytotoxicity in T Cells Against Glioblastoma Cells.
Journal
Biomedicines
Year
2026
Publication types
Journal Article
Revised in PubMed
2026-10-28

Source PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zahedipour FFatemeh
2Sadeghianfard SSogand
3Wisser SSilashttps://orcid.org/0009-0008-9305-7116
4Dinarvand MMeshkat
5Steiner DDenisehttps://orcid.org/0000-0001-6450-9234
6Ramesh AAnjana
7Trosien PPaulhttps://orcid.org/0009-0006-5077-4882
8Leibold JJosef
9Mezger MMarkushttps://orcid.org/0000-0002-0211-2343
10Mohammadian Gol TTahereh

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Förderverein und Stiftung für Krebskranke Kinder Tübingen e.V.PubMed
University Children's Hospital TübingenPubMed
University of TübingenPubMed

Source PubMed

Download CSV of grants

References44

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131951421Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering.Nano Lett2020https://conductscience.org/library/papers/31951421PubMed
233925968In Vitro Evaluation of CD276-CAR NK-92 Functionality, Migration and Invasion Potential in the Presence of Immune Inhibitory Factors of the Tumor Microenvironment.Cells2021https://conductscience.org/library/papers/33925968PubMed
327188790Glioma.Nat Rev Dis Primers2015https://conductscience.org/library/papers/27188790PubMed
439562005Preclinical evaluation of antigen-sensitive B7-H3-targeting nanobody-based CAR-T cells in glioblastoma cautions for on-target, off-tumor toxicity.J Immunother Cancer2024https://conductscience.org/library/papers/39562005PubMed
533959279CAR-NK cells: the next wave of cellular therapy for cancer.Clin Transl Immunology2021https://conductscience.org/library/papers/33959279PubMed
631675094CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016.Neuro Oncol2019https://conductscience.org/library/papers/31675094PubMed
739962245Blood-brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system.Nat Mater2025https://conductscience.org/library/papers/39962245PubMed
829972753Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis.N Engl J Med2018https://conductscience.org/library/papers/29972753PubMed
936361619Preclinical Evaluation of CRISPR-Edited CAR-NK-92 Cells for Off-the-Shelf Treatment of AML and B-ALL.Int J Mol Sci2022https://conductscience.org/library/papers/36361619PubMed
1019544488B7-H3 is a potent inhibitor of human T-cell activation: No evidence for B7-H3 and TREML2 interaction.Eur J Immunol2009https://conductscience.org/library/papers/19544488PubMed
1122271890Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse model.Haematologica2012https://conductscience.org/library/papers/22271890PubMed
1228864289Phase 1 clinical trial of adoptive immunotherapy using "off-the-shelf" activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia.Cytotherapy2017https://conductscience.org/library/papers/28864289PubMed
1334168003Intracerebral administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in patients with recurrent glioblastoma: a phase I clinical trial.J Immunother Cancer2021https://conductscience.org/library/papers/34168003PubMed
1437443804Chimeric Antigen Receptor T Cells in Glioblastoma-Current Concepts and Promising Future.Cells2023https://conductscience.org/library/papers/37443804PubMed
1534373623Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape.Nat Rev Immunol2021https://conductscience.org/library/papers/34373623PubMed
1640653819Lipid nanoparticle formulation for gene editing and RNA-based therapies for glioblastoma.Neuro Oncol2025https://conductscience.org/library/papers/40653819PubMed
1711224528B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production.Nat Immunol2001https://conductscience.org/library/papers/11224528PubMed
1834850635Chemistry of Lipid Nanoparticles for RNA Delivery.Acc Chem Res2022https://conductscience.org/library/papers/34850635PubMed
1939761676mRNA-laden lipid nanoparticle-enabled humanized CD19 CAR-T-cell engineering for the eradication of leukaemic cells.Br J Haematol2025https://conductscience.org/library/papers/39761676PubMed
2018690846The immunoregulatory protein human B7H3 is a tumor-associated antigen that regulates tumor cell migration and invasion.Curr Cancer Drug Targets2008https://conductscience.org/library/papers/18690846PubMed

See all 44 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42940171

GET https://conductscience.org/api/papers/v1/42940171/references?page=2